nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.332	1	CpDpCtD
Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.118	1	CbGaD
Diphenhydramine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.0953	1	CrCrCtD
Diphenhydramine—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0405	0.125	CbGbCtD
Diphenhydramine—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0189	0.0581	CbGbCtD
Diphenhydramine—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0189	0.0581	CbGbCtD
Diphenhydramine—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0174	0.0537	CbGbCtD
Diphenhydramine—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0143	0.0441	CbGbCtD
Diphenhydramine—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0137	0.0422	CbGbCtD
Diphenhydramine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0107	0.0331	CbGbCtD
Diphenhydramine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0105	0.0324	CbGbCtD
Diphenhydramine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00961	0.0296	CbGbCtD
Diphenhydramine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00914	0.0281	CbGbCtD
Diphenhydramine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00914	0.0281	CbGbCtD
Diphenhydramine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00893	0.0275	CbGbCtD
Diphenhydramine—SLC22A2—Metformin—type 2 diabetes mellitus	0.00859	0.0265	CbGbCtD
Diphenhydramine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00843	0.026	CbGbCtD
Diphenhydramine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00814	0.0251	CbGbCtD
Diphenhydramine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00778	0.024	CbGbCtD
Diphenhydramine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0076	0.0234	CbGbCtD
Diphenhydramine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0076	0.0234	CbGbCtD
Diphenhydramine—SLC22A1—Metformin—type 2 diabetes mellitus	0.00746	0.023	CbGbCtD
Diphenhydramine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00701	0.0216	CbGbCtD
Diphenhydramine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00695	0.0214	CbGbCtD
Diphenhydramine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00677	0.0209	CbGbCtD
Diphenhydramine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00641	0.0197	CbGbCtD
Diphenhydramine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00619	0.0191	CbGbCtD
Diphenhydramine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00613	0.0189	CbGbCtD
Diphenhydramine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00579	0.0178	CbGbCtD
Diphenhydramine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00576	0.0177	CbGbCtD
Diphenhydramine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00552	0.017	CbGbCtD
Diphenhydramine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00526	0.0162	CbGbCtD
Diphenhydramine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00505	0.0155	CbGbCtD
Diphenhydramine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00468	0.0144	CbGbCtD
Diphenhydramine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00428	0.0132	CbGbCtD
Diphenhydramine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00395	0.0122	CbGbCtD
Diphenhydramine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00389	0.012	CbGbCtD
Diphenhydramine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00356	0.011	CbGbCtD
Diphenhydramine—Bepridil—KCNQ1—type 2 diabetes mellitus	0.000219	0.0818	CrCbGaD
Diphenhydramine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00169	CcSEcCtD
Diphenhydramine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00169	CcSEcCtD
Diphenhydramine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000138	0.00168	CcSEcCtD
Diphenhydramine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000138	0.00168	CcSEcCtD
Diphenhydramine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000138	0.00168	CcSEcCtD
Diphenhydramine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00167	CcSEcCtD
Diphenhydramine—Chills—Metformin—type 2 diabetes mellitus	0.000138	0.00167	CcSEcCtD
Diphenhydramine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000137	0.00166	CcSEcCtD
Diphenhydramine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000136	0.00166	CcSEcCtD
Diphenhydramine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000136	0.00165	CcSEcCtD
Diphenhydramine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000136	0.00165	CcSEcCtD
Diphenhydramine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000136	0.00165	CcSEcCtD
Diphenhydramine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000135	0.00164	CcSEcCtD
Diphenhydramine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000135	0.00164	CcSEcCtD
Diphenhydramine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000135	0.00164	CcSEcCtD
Diphenhydramine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000135	0.00164	CcSEcCtD
Diphenhydramine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000135	0.00164	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000133	0.00162	CcSEcCtD
Diphenhydramine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000133	0.00161	CcSEcCtD
Diphenhydramine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000132	0.0016	CcSEcCtD
Diphenhydramine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000131	0.00159	CcSEcCtD
Diphenhydramine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00159	CcSEcCtD
Diphenhydramine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00013	0.00158	CcSEcCtD
Diphenhydramine—Vertigo—Orlistat—type 2 diabetes mellitus	0.00013	0.00158	CcSEcCtD
Diphenhydramine—Chills—Irbesartan—type 2 diabetes mellitus	0.00013	0.00158	CcSEcCtD
Diphenhydramine—Palpitations—Valsartan—type 2 diabetes mellitus	0.00013	0.00157	CcSEcCtD
Diphenhydramine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000129	0.00157	CcSEcCtD
Diphenhydramine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000129	0.00156	CcSEcCtD
Diphenhydramine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000128	0.00155	CcSEcCtD
Diphenhydramine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000128	0.00155	CcSEcCtD
Diphenhydramine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000128	0.00155	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000127	0.00155	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000127	0.00155	CcSEcCtD
Diphenhydramine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000127	0.00154	CcSEcCtD
Diphenhydramine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000127	0.00154	CcSEcCtD
Diphenhydramine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000126	0.00153	CcSEcCtD
Diphenhydramine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000126	0.00153	CcSEcCtD
Diphenhydramine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00153	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000126	0.00153	CcSEcCtD
Diphenhydramine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000126	0.00153	CcSEcCtD
Diphenhydramine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000126	0.00153	CcSEcCtD
Diphenhydramine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000125	0.00152	CcSEcCtD
Diphenhydramine—Tremor—Metformin—type 2 diabetes mellitus	0.000125	0.00152	CcSEcCtD
Diphenhydramine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000125	0.00151	CcSEcCtD
Diphenhydramine—Tension—Irbesartan—type 2 diabetes mellitus	0.000124	0.0015	CcSEcCtD
Diphenhydramine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000123	0.0015	CcSEcCtD
Diphenhydramine—Clomifene—CYP11A1—type 2 diabetes mellitus	0.000123	0.046	CrCbGaD
Diphenhydramine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000122	0.00148	CcSEcCtD
Diphenhydramine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000122	0.00148	CcSEcCtD
Diphenhydramine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000122	0.00148	CcSEcCtD
Diphenhydramine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000121	0.00147	CcSEcCtD
Diphenhydramine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000121	0.00146	CcSEcCtD
Diphenhydramine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00012	0.00146	CcSEcCtD
Diphenhydramine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00012	0.00146	CcSEcCtD
Diphenhydramine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00012	0.00145	CcSEcCtD
Diphenhydramine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000119	0.00145	CcSEcCtD
Diphenhydramine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000119	0.00145	CcSEcCtD
Diphenhydramine—Rash—Glipizide—type 2 diabetes mellitus	0.000119	0.00144	CcSEcCtD
Diphenhydramine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000119	0.00144	CcSEcCtD
Diphenhydramine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000119	0.00144	CcSEcCtD
Diphenhydramine—Headache—Glipizide—type 2 diabetes mellitus	0.000118	0.00143	CcSEcCtD
Diphenhydramine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000118	0.00143	CcSEcCtD
Diphenhydramine—Palpitations—Metformin—type 2 diabetes mellitus	0.000118	0.00143	CcSEcCtD
Diphenhydramine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000118	0.00143	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000117	0.00142	CcSEcCtD
Diphenhydramine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000117	0.00142	CcSEcCtD
Diphenhydramine—Tension—Losartan—type 2 diabetes mellitus	0.000116	0.00141	CcSEcCtD
Diphenhydramine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000116	0.00141	CcSEcCtD
Diphenhydramine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00141	CcSEcCtD
Diphenhydramine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000116	0.00141	CcSEcCtD
Diphenhydramine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000116	0.0014	CcSEcCtD
Diphenhydramine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000115	0.0014	CcSEcCtD
Diphenhydramine—Nervousness—Losartan—type 2 diabetes mellitus	0.000115	0.0014	CcSEcCtD
Diphenhydramine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000115	0.00139	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000114	0.00139	CcSEcCtD
Diphenhydramine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000114	0.00138	CcSEcCtD
Diphenhydramine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000114	0.00138	CcSEcCtD
Diphenhydramine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000113	0.00137	CcSEcCtD
Diphenhydramine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000113	0.00137	CcSEcCtD
Diphenhydramine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000112	0.00136	CcSEcCtD
Diphenhydramine—Nausea—Glipizide—type 2 diabetes mellitus	0.000112	0.00136	CcSEcCtD
Diphenhydramine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000112	0.00136	CcSEcCtD
Diphenhydramine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000112	0.00136	CcSEcCtD
Diphenhydramine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000112	0.00136	CcSEcCtD
Diphenhydramine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000111	0.00135	CcSEcCtD
Diphenhydramine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000111	0.00135	CcSEcCtD
Diphenhydramine—Tremor—Losartan—type 2 diabetes mellitus	0.000111	0.00135	CcSEcCtD
Diphenhydramine—Rash—Glimepiride—type 2 diabetes mellitus	0.000111	0.00135	CcSEcCtD
Diphenhydramine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000111	0.00134	CcSEcCtD
Diphenhydramine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000111	0.00134	CcSEcCtD
Diphenhydramine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00134	CcSEcCtD
Diphenhydramine—Headache—Glimepiride—type 2 diabetes mellitus	0.00011	0.00134	CcSEcCtD
Diphenhydramine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00133	CcSEcCtD
Diphenhydramine—Agitation—Losartan—type 2 diabetes mellitus	0.000109	0.00132	CcSEcCtD
Diphenhydramine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000109	0.00132	CcSEcCtD
Diphenhydramine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00132	CcSEcCtD
Diphenhydramine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000108	0.00131	CcSEcCtD
Diphenhydramine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000107	0.0013	CcSEcCtD
Diphenhydramine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000107	0.0013	CcSEcCtD
Diphenhydramine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000107	0.0013	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000107	0.00129	CcSEcCtD
Diphenhydramine—Vertigo—Losartan—type 2 diabetes mellitus	0.000106	0.00129	CcSEcCtD
Diphenhydramine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000106	0.00129	CcSEcCtD
Diphenhydramine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000106	0.00129	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000105	0.00128	CcSEcCtD
Diphenhydramine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000105	0.00128	CcSEcCtD
Diphenhydramine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00127	CcSEcCtD
Diphenhydramine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000105	0.00127	CcSEcCtD
Diphenhydramine—Palpitations—Losartan—type 2 diabetes mellitus	0.000105	0.00127	CcSEcCtD
Diphenhydramine—Bepridil—CALM1—type 2 diabetes mellitus	0.000105	0.039	CrCbGaD
Diphenhydramine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000104	0.00127	CcSEcCtD
Diphenhydramine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000104	0.00126	CcSEcCtD
Diphenhydramine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000104	0.00126	CcSEcCtD
Diphenhydramine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000104	0.00126	CcSEcCtD
Diphenhydramine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000104	0.00126	CcSEcCtD
Diphenhydramine—Anorexia—Metformin—type 2 diabetes mellitus	0.000104	0.00126	CcSEcCtD
Diphenhydramine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000103	0.00126	CcSEcCtD
Diphenhydramine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000103	0.00125	CcSEcCtD
Diphenhydramine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000103	0.00125	CcSEcCtD
Diphenhydramine—Constipation—Valsartan—type 2 diabetes mellitus	0.000102	0.00124	CcSEcCtD
Diphenhydramine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000102	0.00124	CcSEcCtD
Diphenhydramine—Hypotension—Metformin—type 2 diabetes mellitus	0.000102	0.00124	CcSEcCtD
Diphenhydramine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000101	0.00122	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000101	0.00122	CcSEcCtD
Diphenhydramine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.0001	0.00122	CcSEcCtD
Diphenhydramine—Rash—Bromocriptine—type 2 diabetes mellitus	0.0001	0.00121	CcSEcCtD
Diphenhydramine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.99e-05	0.00121	CcSEcCtD
Diphenhydramine—Tension—Ramipril—type 2 diabetes mellitus	9.97e-05	0.00121	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.94e-05	0.00121	CcSEcCtD
Diphenhydramine—Headache—Bromocriptine—type 2 diabetes mellitus	9.94e-05	0.00121	CcSEcCtD
Diphenhydramine—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.92e-05	0.0012	CcSEcCtD
Diphenhydramine—Nervousness—Ramipril—type 2 diabetes mellitus	9.87e-05	0.0012	CcSEcCtD
Diphenhydramine—Dry mouth—Losartan—type 2 diabetes mellitus	9.87e-05	0.0012	CcSEcCtD
Diphenhydramine—Anorexia—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.00119	CcSEcCtD
Diphenhydramine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.78e-05	0.00119	CcSEcCtD
Diphenhydramine—Confusional state—Losartan—type 2 diabetes mellitus	9.75e-05	0.00118	CcSEcCtD
Diphenhydramine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.74e-05	0.00118	CcSEcCtD
Diphenhydramine—Somnolence—Metformin—type 2 diabetes mellitus	9.68e-05	0.00118	CcSEcCtD
Diphenhydramine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.00117	CcSEcCtD
Diphenhydramine—Dyspepsia—Metformin—type 2 diabetes mellitus	9.59e-05	0.00116	CcSEcCtD
Diphenhydramine—Tremor—Ramipril—type 2 diabetes mellitus	9.52e-05	0.00116	CcSEcCtD
Diphenhydramine—Urticaria—Valsartan—type 2 diabetes mellitus	9.5e-05	0.00115	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.47e-05	0.00115	CcSEcCtD
Diphenhydramine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.47e-05	0.00115	CcSEcCtD
Diphenhydramine—Tachycardia—Losartan—type 2 diabetes mellitus	9.44e-05	0.00115	CcSEcCtD
Diphenhydramine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.42e-05	0.00114	CcSEcCtD
Diphenhydramine—Fatigue—Metformin—type 2 diabetes mellitus	9.39e-05	0.00114	CcSEcCtD
Diphenhydramine—Urticaria—Orlistat—type 2 diabetes mellitus	9.39e-05	0.00114	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.35e-05	0.00114	CcSEcCtD
Diphenhydramine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.34e-05	0.00113	CcSEcCtD
Diphenhydramine—Agitation—Ramipril—type 2 diabetes mellitus	9.34e-05	0.00113	CcSEcCtD
Diphenhydramine—Constipation—Metformin—type 2 diabetes mellitus	9.31e-05	0.00113	CcSEcCtD
Diphenhydramine—Captodiame—HTR2C—type 2 diabetes mellitus	9.31e-05	0.0347	CrCbGaD
Diphenhydramine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.00112	CcSEcCtD
Diphenhydramine—Anorexia—Losartan—type 2 diabetes mellitus	9.22e-05	0.00112	CcSEcCtD
Diphenhydramine—Vomiting—Glyburide—type 2 diabetes mellitus	9.22e-05	0.00112	CcSEcCtD
Diphenhydramine—Rash—Glyburide—type 2 diabetes mellitus	9.14e-05	0.00111	CcSEcCtD
Diphenhydramine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.00111	CcSEcCtD
Diphenhydramine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.13e-05	0.00111	CcSEcCtD
Diphenhydramine—Vertigo—Ramipril—type 2 diabetes mellitus	9.13e-05	0.00111	CcSEcCtD
Diphenhydramine—Headache—Glyburide—type 2 diabetes mellitus	9.08e-05	0.0011	CcSEcCtD
Diphenhydramine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.0011	CcSEcCtD
Diphenhydramine—Hypotension—Losartan—type 2 diabetes mellitus	9.04e-05	0.0011	CcSEcCtD
Diphenhydramine—Palpitations—Ramipril—type 2 diabetes mellitus	8.98e-05	0.00109	CcSEcCtD
Diphenhydramine—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.98e-05	0.00109	CcSEcCtD
Diphenhydramine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.00108	CcSEcCtD
Diphenhydramine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.91e-05	0.00108	CcSEcCtD
Diphenhydramine—Fatigue—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.00108	CcSEcCtD
Diphenhydramine—Convulsion—Ramipril—type 2 diabetes mellitus	8.81e-05	0.00107	CcSEcCtD
Diphenhydramine—Constipation—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.00107	CcSEcCtD
Diphenhydramine—Reboxetine—HTR2C—type 2 diabetes mellitus	8.75e-05	0.0326	CrCbGaD
Diphenhydramine—Insomnia—Losartan—type 2 diabetes mellitus	8.75e-05	0.00106	CcSEcCtD
Diphenhydramine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.69e-05	0.00105	CcSEcCtD
Diphenhydramine—Urticaria—Metformin—type 2 diabetes mellitus	8.65e-05	0.00105	CcSEcCtD
Diphenhydramine—Nausea—Glyburide—type 2 diabetes mellitus	8.61e-05	0.00105	CcSEcCtD
Diphenhydramine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.61e-05	0.00105	CcSEcCtD
Diphenhydramine—Somnolence—Losartan—type 2 diabetes mellitus	8.6e-05	0.00104	CcSEcCtD
Diphenhydramine—Asthenia—Valsartan—type 2 diabetes mellitus	8.58e-05	0.00104	CcSEcCtD
Diphenhydramine—Dyspepsia—Losartan—type 2 diabetes mellitus	8.52e-05	0.00103	CcSEcCtD
Diphenhydramine—Bedaquiline—CYP3A4—type 2 diabetes mellitus	8.49e-05	0.0316	CrCbGaD
Diphenhydramine—Asthenia—Orlistat—type 2 diabetes mellitus	8.48e-05	0.00103	CcSEcCtD
Diphenhydramine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.00103	CcSEcCtD
Diphenhydramine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.46e-05	0.00103	CcSEcCtD
Diphenhydramine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.41e-05	0.00102	CcSEcCtD
Diphenhydramine—Confusional state—Ramipril—type 2 diabetes mellitus	8.36e-05	0.00102	CcSEcCtD
Diphenhydramine—Fatigue—Losartan—type 2 diabetes mellitus	8.34e-05	0.00101	CcSEcCtD
Diphenhydramine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.28e-05	0.001	CcSEcCtD
Diphenhydramine—Constipation—Losartan—type 2 diabetes mellitus	8.27e-05	0.001	CcSEcCtD
Diphenhydramine—Rash—Gliclazide—type 2 diabetes mellitus	8.21e-05	0.000996	CcSEcCtD
Diphenhydramine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.2e-05	0.000996	CcSEcCtD
Diphenhydramine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.18e-05	0.000993	CcSEcCtD
Diphenhydramine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000991	CcSEcCtD
Diphenhydramine—Headache—Gliclazide—type 2 diabetes mellitus	8.16e-05	0.00099	CcSEcCtD
Diphenhydramine—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	8.15e-05	0.0304	CrCbGaD
Diphenhydramine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000986	CcSEcCtD
Diphenhydramine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000983	CcSEcCtD
Diphenhydramine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.09e-05	0.000982	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.02e-05	0.000973	CcSEcCtD
Diphenhydramine—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.97e-05	0.000968	CcSEcCtD
Diphenhydramine—Dizziness—Valsartan—type 2 diabetes mellitus	7.91e-05	0.00096	CcSEcCtD
Diphenhydramine—Anorexia—Ramipril—type 2 diabetes mellitus	7.91e-05	0.00096	CcSEcCtD
Diphenhydramine—Dizziness—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000949	CcSEcCtD
Diphenhydramine—Asthenia—Metformin—type 2 diabetes mellitus	7.82e-05	0.000949	CcSEcCtD
Diphenhydramine—Hypotension—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000941	CcSEcCtD
Diphenhydramine—Nausea—Gliclazide—type 2 diabetes mellitus	7.73e-05	0.000939	CcSEcCtD
Diphenhydramine—Urticaria—Losartan—type 2 diabetes mellitus	7.69e-05	0.000933	CcSEcCtD
Diphenhydramine—Vomiting—Valsartan—type 2 diabetes mellitus	7.61e-05	0.000923	CcSEcCtD
Diphenhydramine—Rash—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000915	CcSEcCtD
Diphenhydramine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000915	CcSEcCtD
Diphenhydramine—Vomiting—Orlistat—type 2 diabetes mellitus	7.52e-05	0.000912	CcSEcCtD
Diphenhydramine—Insomnia—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000911	CcSEcCtD
Diphenhydramine—Headache—Valsartan—type 2 diabetes mellitus	7.49e-05	0.00091	CcSEcCtD
Diphenhydramine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.45e-05	0.000905	CcSEcCtD
Diphenhydramine—Rash—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000905	CcSEcCtD
Diphenhydramine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000904	CcSEcCtD
Diphenhydramine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000904	CcSEcCtD
Diphenhydramine—Headache—Orlistat—type 2 diabetes mellitus	7.4e-05	0.000899	CcSEcCtD
Diphenhydramine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000895	CcSEcCtD
Diphenhydramine—Somnolence—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000895	CcSEcCtD
Diphenhydramine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000886	CcSEcCtD
Diphenhydramine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000875	CcSEcCtD
Diphenhydramine—Dizziness—Metformin—type 2 diabetes mellitus	7.2e-05	0.000874	CcSEcCtD
Diphenhydramine—Fatigue—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000868	CcSEcCtD
Diphenhydramine—Nausea—Valsartan—type 2 diabetes mellitus	7.11e-05	0.000862	CcSEcCtD
Diphenhydramine—Constipation—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000861	CcSEcCtD
Diphenhydramine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.000854	CcSEcCtD
Diphenhydramine—Nausea—Orlistat—type 2 diabetes mellitus	7.02e-05	0.000852	CcSEcCtD
Diphenhydramine—Asthenia—Losartan—type 2 diabetes mellitus	6.94e-05	0.000843	CcSEcCtD
Diphenhydramine—Vomiting—Metformin—type 2 diabetes mellitus	6.93e-05	0.000841	CcSEcCtD
Diphenhydramine—Rash—Metformin—type 2 diabetes mellitus	6.87e-05	0.000834	CcSEcCtD
Diphenhydramine—Dermatitis—Metformin—type 2 diabetes mellitus	6.86e-05	0.000833	CcSEcCtD
Diphenhydramine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.84e-05	0.00083	CcSEcCtD
Diphenhydramine—Headache—Metformin—type 2 diabetes mellitus	6.82e-05	0.000828	CcSEcCtD
Diphenhydramine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000825	CcSEcCtD
Diphenhydramine—Promethazine—CALM1—type 2 diabetes mellitus	6.7e-05	0.025	CrCbGaD
Diphenhydramine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.62e-05	0.000803	CcSEcCtD
Diphenhydramine—Urticaria—Ramipril—type 2 diabetes mellitus	6.59e-05	0.0008	CcSEcCtD
Diphenhydramine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000793	CcSEcCtD
Diphenhydramine—Rash—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000787	CcSEcCtD
Diphenhydramine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000786	CcSEcCtD
Diphenhydramine—Nausea—Metformin—type 2 diabetes mellitus	6.47e-05	0.000785	CcSEcCtD
Diphenhydramine—Headache—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000782	CcSEcCtD
Diphenhydramine—Dizziness—Losartan—type 2 diabetes mellitus	6.4e-05	0.000777	CcSEcCtD
Diphenhydramine—Vomiting—Losartan—type 2 diabetes mellitus	6.15e-05	0.000747	CcSEcCtD
Diphenhydramine—Nausea—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000741	CcSEcCtD
Diphenhydramine—Rash—Losartan—type 2 diabetes mellitus	6.1e-05	0.00074	CcSEcCtD
Diphenhydramine—Dermatitis—Losartan—type 2 diabetes mellitus	6.09e-05	0.00074	CcSEcCtD
Diphenhydramine—Headache—Losartan—type 2 diabetes mellitus	6.06e-05	0.000736	CcSEcCtD
Diphenhydramine—Asthenia—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000722	CcSEcCtD
Diphenhydramine—Nausea—Losartan—type 2 diabetes mellitus	5.75e-05	0.000698	CcSEcCtD
Diphenhydramine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000689	CcSEcCtD
Diphenhydramine—Dizziness—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000666	CcSEcCtD
Diphenhydramine—Vomiting—Ramipril—type 2 diabetes mellitus	5.27e-05	0.00064	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A2—type 2 diabetes mellitus	5.24e-05	0.0195	CrCbGaD
Diphenhydramine—Rash—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000635	CcSEcCtD
Diphenhydramine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000634	CcSEcCtD
Diphenhydramine—Headache—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000631	CcSEcCtD
Diphenhydramine—Bifonazole—CYP2E1—type 2 diabetes mellitus	4.95e-05	0.0184	CrCbGaD
Diphenhydramine—Nausea—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000598	CcSEcCtD
Diphenhydramine—Clomifene—CYP2E1—type 2 diabetes mellitus	4.76e-05	0.0177	CrCbGaD
Diphenhydramine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	4.53e-05	0.0169	CrCbGaD
Diphenhydramine—Clomifene—CYP1A2—type 2 diabetes mellitus	4.53e-05	0.0169	CrCbGaD
Diphenhydramine—Reboxetine—CYP3A4—type 2 diabetes mellitus	4.37e-05	0.0163	CrCbGaD
Diphenhydramine—Phenytoin—ABCC2—type 2 diabetes mellitus	4.11e-05	0.0153	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	3.91e-05	0.0146	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—type 2 diabetes mellitus	3.87e-05	0.0144	CrCbGaD
Diphenhydramine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	3.86e-05	0.0144	CrCbGaD
Diphenhydramine—Warfarin—CYP1A2—type 2 diabetes mellitus	3.77e-05	0.0141	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	3.69e-05	0.0137	CrCbGaD
Diphenhydramine—Atomoxetine—HTR2C—type 2 diabetes mellitus	3.52e-05	0.0131	CrCbGaD
Diphenhydramine—Toremifene—CYP3A4—type 2 diabetes mellitus	3.47e-05	0.0129	CrCbGaD
Diphenhydramine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	3.39e-05	0.0126	CrCbGaD
Diphenhydramine—Alimemazine—CYP3A4—type 2 diabetes mellitus	3.25e-05	0.0121	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—type 2 diabetes mellitus	3.2e-05	0.0119	CrCbGaD
Diphenhydramine—Trimipramine—ADRA2A—type 2 diabetes mellitus	3.15e-05	0.0117	CrCbGaD
Diphenhydramine—Tamoxifen—ABCC2—type 2 diabetes mellitus	3.13e-05	0.0117	CrCbGaD
Diphenhydramine—Bifonazole—CYP3A4—type 2 diabetes mellitus	3.11e-05	0.0116	CrCbGaD
Diphenhydramine—Modafinil—CYP1A2—type 2 diabetes mellitus	3.09e-05	0.0115	CrCbGaD
Diphenhydramine—Doxepin—ADRA2A—type 2 diabetes mellitus	3e-05	0.0112	CrCbGaD
Diphenhydramine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	3e-05	0.0112	CrCbGaD
Diphenhydramine—Clomifene—CYP3A4—type 2 diabetes mellitus	3e-05	0.0112	CrCbGaD
Diphenhydramine—Cinnarizine—CYP1A2—type 2 diabetes mellitus	2.99e-05	0.0111	CrCbGaD
Diphenhydramine—Trimipramine—HTR2C—type 2 diabetes mellitus	2.9e-05	0.0108	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—type 2 diabetes mellitus	2.85e-05	0.0106	CrCbGaD
Diphenhydramine—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	2.82e-05	0.0105	CrCbGaD
Diphenhydramine—Doxepin—HTR2C—type 2 diabetes mellitus	2.76e-05	0.0103	CrCbGaD
Diphenhydramine—Promazine—ADRA2A—type 2 diabetes mellitus	2.67e-05	0.00994	CrCbGaD
Diphenhydramine—Phenylbutazone—CYP3A4—type 2 diabetes mellitus	2.61e-05	0.00974	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—type 2 diabetes mellitus	2.56e-05	0.00953	CrCbGaD
Diphenhydramine—Warfarin—CYP3A4—type 2 diabetes mellitus	2.5e-05	0.00931	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	2.46e-05	0.00918	CrCbGaD
Diphenhydramine—Phenprocoumon—ALB—type 2 diabetes mellitus	2.46e-05	0.00916	CrCbGaD
Diphenhydramine—Promazine—HTR2C—type 2 diabetes mellitus	2.46e-05	0.00915	CrCbGaD
Diphenhydramine—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	2.34e-05	0.00872	CrCbGaD
Diphenhydramine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	2.32e-05	0.00865	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	2.2e-05	0.00819	CrCbGaD
Diphenhydramine—Warfarin—ALB—type 2 diabetes mellitus	2.18e-05	0.00812	CrCbGaD
Diphenhydramine—Imipramine—HTR2C—type 2 diabetes mellitus	2.15e-05	0.00801	CrCbGaD
Diphenhydramine—Amitriptyline—HTR2C—type 2 diabetes mellitus	2.14e-05	0.00796	CrCbGaD
Diphenhydramine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	2.14e-05	0.00796	CrCbGaD
Diphenhydramine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	2.13e-05	0.00795	CrCbGaD
Diphenhydramine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	2.1e-05	0.00781	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	2.09e-05	0.00779	CrCbGaD
Diphenhydramine—Doxepin—CYP1A2—type 2 diabetes mellitus	2.08e-05	0.00777	CrCbGaD
Diphenhydramine—Methadone—CYP1A2—type 2 diabetes mellitus	2.07e-05	0.00773	CrCbGaD
Diphenhydramine—Modafinil—CYP3A4—type 2 diabetes mellitus	2.05e-05	0.00763	CrCbGaD
Diphenhydramine—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	2.02e-05	0.00754	CrCbGaD
Diphenhydramine—Fentanyl—CYP3A4—type 2 diabetes mellitus	2e-05	0.00746	CrCbGaD
Diphenhydramine—Promazine—CYP1A2—type 2 diabetes mellitus	1.85e-05	0.0069	CrCbGaD
Diphenhydramine—Phenytoin—CYP3A4—type 2 diabetes mellitus	1.82e-05	0.00676	CrCbGaD
Diphenhydramine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	1.77e-05	0.00661	CrCbGaD
Diphenhydramine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	1.76e-05	0.00656	CrCbGaD
Diphenhydramine—Imipramine—CYP2E1—type 2 diabetes mellitus	1.71e-05	0.00635	CrCbGaD
Diphenhydramine—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	1.7e-05	0.00632	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	1.69e-05	0.00631	CrCbGaD
Diphenhydramine—Imipramine—CYP1A2—type 2 diabetes mellitus	1.62e-05	0.00604	CrCbGaD
Diphenhydramine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	1.61e-05	0.00601	CrCbGaD
Diphenhydramine—Phenytoin—ALB—type 2 diabetes mellitus	1.58e-05	0.0059	CrCbGaD
Diphenhydramine—Trimipramine—CYP3A4—type 2 diabetes mellitus	1.45e-05	0.0054	CrCbGaD
Diphenhydramine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	1.38e-05	0.00516	CrCbGaD
Diphenhydramine—Doxepin—CYP3A4—type 2 diabetes mellitus	1.38e-05	0.00514	CrCbGaD
Diphenhydramine—Methadone—CYP3A4—type 2 diabetes mellitus	1.37e-05	0.00512	CrCbGaD
Diphenhydramine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	1.34e-05	0.00501	CrCbGaD
Diphenhydramine—Promazine—CYP3A4—type 2 diabetes mellitus	1.23e-05	0.00457	CrCbGaD
Diphenhydramine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.07e-05	0.004	CrCbGaD
Diphenhydramine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	1.07e-05	0.00398	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—type 2 diabetes mellitus	9.31e-06	0.00347	CrCbGaD
Diphenhydramine—SLC22A2—nephron tubule—type 2 diabetes mellitus	4.77e-06	0.0695	CbGeAlD
Diphenhydramine—PTGS1—artery—type 2 diabetes mellitus	4.75e-06	0.0692	CbGeAlD
Diphenhydramine—SLC22A2—kidney—type 2 diabetes mellitus	4.19e-06	0.0611	CbGeAlD
Diphenhydramine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	4.08e-06	0.0595	CbGeAlD
Diphenhydramine—PTGS1—endothelium—type 2 diabetes mellitus	4.01e-06	0.0585	CbGeAlD
Diphenhydramine—CYP2C18—liver—type 2 diabetes mellitus	3.39e-06	0.0495	CbGeAlD
Diphenhydramine—CHRM2—cardiovascular system—type 2 diabetes mellitus	3.08e-06	0.0449	CbGeAlD
Diphenhydramine—SLC22A1—kidney—type 2 diabetes mellitus	2.96e-06	0.0432	CbGeAlD
Diphenhydramine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	2.82e-06	6.29e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	2.82e-06	6.29e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.8e-06	6.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.8e-06	6.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	2.79e-06	6.22e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	2.78e-06	6.22e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.78e-06	6.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	2.77e-06	6.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.77e-06	6.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.77e-06	6.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.76e-06	6.17e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	2.76e-06	6.16e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	2.75e-06	6.14e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.75e-06	6.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	2.74e-06	6.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	2.74e-06	6.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	2.74e-06	6.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.74e-06	6.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	2.74e-06	6.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	2.74e-06	6.11e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.74e-06	6.11e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.73e-06	6.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.72e-06	6.08e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	2.72e-06	6.08e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	2.7e-06	6.03e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.68e-06	5.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	2.68e-06	5.98e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	5.96e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—adipose tissue—type 2 diabetes mellitus	2.67e-06	0.0389	CbGeAlD
Diphenhydramine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.67e-06	5.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.66e-06	5.93e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	2.65e-06	5.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.63e-06	5.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.63e-06	5.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.63e-06	5.87e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	2.61e-06	5.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.61e-06	5.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.61e-06	5.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.61e-06	5.82e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.57e-06	5.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.56e-06	5.72e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	2.56e-06	5.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.56e-06	5.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	2.56e-06	5.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.54e-06	5.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.53e-06	5.64e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.52e-06	5.63e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	2.52e-06	5.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.52e-06	5.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.52e-06	5.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	2.51e-06	5.61e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	2.51e-06	5.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.5e-06	5.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.5e-06	5.58e-05	CbGpPWpGaD
Diphenhydramine—SLC22A5—retina—type 2 diabetes mellitus	2.49e-06	0.0362	CbGeAlD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.47e-06	5.51e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	2.47e-06	5.5e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.46e-06	5.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.46e-06	5.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.46e-06	5.49e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	2.45e-06	5.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	2.43e-06	5.43e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.42e-06	5.39e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	5.38e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	5.38e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.39e-06	5.35e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.39e-06	5.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.39e-06	5.33e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.38e-06	5.32e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.38e-06	5.32e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.38e-06	5.31e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.36e-06	5.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.36e-06	5.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.36e-06	5.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.36e-06	5.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.35e-06	5.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.35e-06	5.25e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	2.35e-06	5.25e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.35e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.34e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.34e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—SLC22A5—nephron tubule—type 2 diabetes mellitus	2.34e-06	0.0341	CbGeAlD
Diphenhydramine—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.34e-06	5.22e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.33e-06	5.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.33e-06	5.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.32e-06	5.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.31e-06	5.15e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.3e-06	5.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.29e-06	5.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.29e-06	5.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.27e-06	5.06e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.25e-06	5.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.25e-06	5.02e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	5.02e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	5.02e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.23e-06	4.97e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.21e-06	4.92e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.2e-06	4.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.19e-06	4.89e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.17e-06	4.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.17e-06	4.85e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.17e-06	4.85e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.16e-06	4.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.16e-06	4.83e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.16e-06	4.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.15e-06	4.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.15e-06	4.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.15e-06	4.8e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.14e-06	4.78e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	4.78e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.13e-06	4.76e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.13e-06	4.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.13e-06	4.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.11e-06	4.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.1e-06	4.7e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.1e-06	4.68e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.08e-06	4.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.08e-06	4.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.07e-06	4.62e-05	CbGpPWpGaD
Diphenhydramine—SLC22A5—kidney—type 2 diabetes mellitus	2.06e-06	0.03	CbGeAlD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	4.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.05e-06	4.58e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.05e-06	4.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.04e-06	4.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.04e-06	4.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—nephron tubule—type 2 diabetes mellitus	2.03e-06	0.0296	CbGeAlD
Diphenhydramine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.02e-06	4.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.01e-06	4.5e-05	CbGpPWpGaD
Diphenhydramine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	2e-06	0.0292	CbGeAlD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2e-06	4.46e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	1.99e-06	4.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.98e-06	4.41e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.96e-06	4.38e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.96e-06	4.38e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.96e-06	4.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.94e-06	4.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.94e-06	4.32e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.93e-06	4.31e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.93e-06	4.31e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.93e-06	4.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.93e-06	4.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.92e-06	4.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.92e-06	4.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.91e-06	4.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.9e-06	4.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.9e-06	4.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.89e-06	4.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.89e-06	4.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.88e-06	4.19e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—liver—type 2 diabetes mellitus	1.87e-06	0.0273	CbGeAlD
Diphenhydramine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.87e-06	4.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.86e-06	4.16e-05	CbGpPWpGaD
Diphenhydramine—SLC22A5—adipose tissue—type 2 diabetes mellitus	1.85e-06	0.027	CbGeAlD
Diphenhydramine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.85e-06	4.14e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.84e-06	4.11e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.84e-06	4.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.84e-06	4.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.84e-06	4.1e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.83e-06	4.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.83e-06	4.09e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	1.83e-06	0.0266	CbGeAlD
Diphenhydramine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	1.81e-06	0.0264	CbGeAlD
Diphenhydramine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.81e-06	4.04e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.81e-06	4.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.8e-06	4.02e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.8e-06	4.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—kidney—type 2 diabetes mellitus	1.79e-06	0.026	CbGeAlD
Diphenhydramine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.79e-06	3.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.79e-06	3.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.78e-06	3.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.78e-06	3.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.76e-06	3.94e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.75e-06	3.92e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.75e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.75e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.75e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.73e-06	3.86e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.72e-06	3.84e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.72e-06	3.84e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.71e-06	3.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.69e-06	3.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.68e-06	3.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.67e-06	3.74e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	1.67e-06	3.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.66e-06	3.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.66e-06	3.7e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—cardiovascular system—type 2 diabetes mellitus	1.65e-06	0.0241	CbGeAlD
Diphenhydramine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.65e-06	3.68e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.64e-06	3.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.64e-06	3.67e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.64e-06	3.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.64e-06	3.66e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.63e-06	3.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-06	3.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.62e-06	3.63e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.62e-06	3.61e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—kidney—type 2 diabetes mellitus	1.62e-06	0.0235	CbGeAlD
Diphenhydramine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.59e-06	3.55e-05	CbGpPWpGaD
Diphenhydramine—HRH1—adipose tissue—type 2 diabetes mellitus	1.57e-06	0.0229	CbGeAlD
Diphenhydramine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-06	3.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.57e-06	3.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.54e-06	3.44e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.51e-06	3.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.5e-06	3.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.48e-06	3.31e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.48e-06	3.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.47e-06	3.29e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.47e-06	3.29e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.46e-06	3.26e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—adipose tissue—type 2 diabetes mellitus	1.46e-06	0.0212	CbGeAlD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.45e-06	3.24e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.44e-06	3.22e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—liver—type 2 diabetes mellitus	1.44e-06	0.021	CbGeAlD
Diphenhydramine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.43e-06	3.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.43e-06	3.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.42e-06	3.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.41e-06	3.15e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.41e-06	3.14e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.4e-06	3.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.4e-06	3.13e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.4e-06	3.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.39e-06	3.1e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.39e-06	3.1e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.38e-06	3.08e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.36e-06	3.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.36e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-06	3.01e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-06	3.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.34e-06	2.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—kidney—type 2 diabetes mellitus	1.33e-06	0.0194	CbGeAlD
Diphenhydramine—SLC22A5—liver—type 2 diabetes mellitus	1.3e-06	0.019	CbGeAlD
Diphenhydramine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	2.9e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	2.89e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.29e-06	2.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.27e-06	2.84e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	2.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.24e-06	2.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-06	2.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-06	2.75e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.23e-06	2.75e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	2.73e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.2e-06	2.68e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—liver—type 2 diabetes mellitus	1.18e-06	0.0172	CbGeAlD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	2.58e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.14e-06	2.54e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-06	2.53e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	2.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—liver—type 2 diabetes mellitus	1.13e-06	0.0165	CbGeAlD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	2.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—liver—type 2 diabetes mellitus	1.12e-06	0.0163	CbGeAlD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.11e-06	2.49e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	2.47e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.1e-06	2.45e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	2.4e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	2.35e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	2.35e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	2.31e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	9.62e-07	2.15e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.71e-07	1.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.57e-07	1.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—liver—type 2 diabetes mellitus	8.39e-07	0.0122	CbGeAlD
Diphenhydramine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	8.21e-07	1.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.03e-07	1.79e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.9e-07	1.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.2e-07	1.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.71e-07	1.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.66e-07	1.26e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.83e-07	1.08e-05	CbGpPWpGaD
